Pfizer (PFE) Goodwill (2009 - 2026)

Pfizer (PFE) has 18 years of Goodwill data on file, last reported at $71.4 billion in Q1 2026.

• Goodwill for Q1 2026 came in at $71.4 billion, up 4.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $71.4 billion (up 4.33% YoY), and the FY2025 annual result was $71.3 billion, up 3.99% from the prior year.
• Goodwill was little changed at $71.4 billion in Q1 2026 per PFE's latest filing, from $71.3 billion in the prior quarter.
• Over five years, Goodwill peaked at $71.4 billion in Q1 2026 and troughed at $49.4 billion in Q4 2022.
• A 5-year average of $61.6 billion and a median of $68.4 billion in 2025 frame the typical range for Goodwill.
• The sharpest annual moves came in 2024 and 2025: Goodwill jumped 34.62% in 2024, then dropped 1.23% in 2025.
• A 5-year view of Goodwill shows it stood at $51.4 billion in 2022, then surged by 31.94% to $67.8 billion in 2023, then climbed by 1.1% to $68.5 billion in 2024, then increased by 3.99% to $71.3 billion in 2025, then advanced by 0.2% to $71.4 billion in 2026.
• Business Quant data shows PFE's Goodwill at $71.4 billion in Q1 2026, $71.3 billion in Q4 2025, and $69.1 billion in Q3 2025.